QLIS Stock Overview
A clinical stage company, focuses on the development, production, and distribution of pain management and other central nervous system (CNS) based solutions in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Qualis Innovations, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.27 |
| 52 Week High | US$0.94 |
| 52 Week Low | US$0.26 |
| Beta | -2.76 |
| 11 Month Change | 0.57% |
| 3 Month Change | n/a |
| 1 Year Change | -11.33% |
| 33 Year Change | -88.13% |
| 5 Year Change | n/a |
| Change since IPO | -92.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| QLIS | US Specialty Retail | US Market | |
|---|---|---|---|
| 7D | 0.5% | -1.5% | -1.0% |
| 1Y | -11.3% | 26.0% | 30.3% |
Return vs Industry: QLIS underperformed the US Specialty Retail industry which returned 27.6% over the past year.
Return vs Market: QLIS underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| QLIS volatility | |
|---|---|
| QLIS Average Weekly Movement | n/a |
| Specialty Retail Industry Average Movement | 7.3% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: QLIS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine QLIS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Patrick Adams | www.qualisinnovations.com |
Qualis Innovations, Inc., a clinical stage company, focuses on the development, production, and distribution of pain management and other central nervous system (CNS) based solutions in the United States. It develops SOLACE, a non-invasive medical device to use electromagnetic induction to generate deep heat below the surface of the skin to reduce and relieve pain. Qualis Innovations, Inc. is headquartered in Centennial, Colorado.
Qualis Innovations, Inc. Fundamentals Summary
| QLIS fundamental statistics | |
|---|---|
| Market cap | US$5.44m |
| Earnings (TTM) | US$873.16k |
| Revenue (TTM) | n/a |
6.2x
P/E Ratio0.0x
P/S RatioIs QLIS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QLIS income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$40.18k |
| Gross Profit | -US$40.17k |
| Other Expenses | -US$913.33k |
| Earnings | US$873.16k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.043 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 137.9% |
How did QLIS perform over the long term?
See historical performance and comparison